Cyclooxygenase-2 functions as a downstream mediator of lysophosphatidic acid to promote aggressive behavior in ovarian carcinoma cells
- PMID: 15781636
- DOI: 10.1158/0008.5472.CAN-04-2781
Cyclooxygenase-2 functions as a downstream mediator of lysophosphatidic acid to promote aggressive behavior in ovarian carcinoma cells
Abstract
Elevated levels of the bioactive lipid lysophosphatidic acid (LPA) are detectable in the majority of patients with both early- and late-stage ovarian cancer, suggesting that LPA promotes early events in ovarian carcinoma dissemination. LPA contributes to the development, progression, and metastasis of ovarian cancer in part by inducing the expression of genes that contribute to proliferation, survival, or invasion, including cyclooxgenase-2 (COX-2) and matrix metalloproteinase-2 (MMP-2). We have previously shown that LPA promotes proMMP-2 activation and MMP-2-dependent migration and invasion in ovarian cancer cells. The purpose of the current study was to determine whether the effect of LPA on acquisition of the metastatic phenotype in ovarian cancer cells is mediated via a COX-2-dependent mechanism. Immunohistochemical analysis of 173 ovarian tumors showed strong COX-2 immunoreactivity in 63% of tumor specimens, including 50% of borderline tumors. LPA increased COX-2 protein expression in a time- and concentration-dependent manner in two of three immortalized borderline ovarian epithelial cells as well as in four of six ovarian cancer cell lines. This was accomplished by both activation of the Edg/LPA receptor and LPA-mediated transactivation of the epidermal growth factor receptor, which increased COX-2 expression via the Ras/mitogen-activated protein kinase pathway. COX-2 also played a role in LPA-induced invasion and migration, as treatment with the COX-2 specific inhibitor NS-398 reduced LPA-induced proMMP-2 protein expression and activation and blocked MMP-dependent motility and invasive activity. These data show that COX-2 functions as a downstream mediator of LPA to potentiate aggressive cellular behavior.
Similar articles
-
Lysophosphatidic acid promotes matrix metalloproteinase (MMP) activation and MMP-dependent invasion in ovarian cancer cells.Cancer Res. 2001 Apr 1;61(7):3194-9. Cancer Res. 2001. PMID: 11306508
-
Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells.Clin Cancer Res. 2004 Jul 15;10(14):4670-9. doi: 10.1158/1078-0432.CCR-04-0315. Clin Cancer Res. 2004. PMID: 15269139
-
Lysophosphatidic Acid Stimulates Ovarian Cancer Cell Migration via a Ras-MEK Kinase 1 Pathway.Cancer Res. 2004 Jun 15;64(12):4209-17. doi: 10.1158/0008-5472.CAN-04-0060. Cancer Res. 2004. PMID: 15205333
-
Roles of LPA in ovarian cancer development and progression.Future Oncol. 2009 Dec;5(10):1659-73. doi: 10.2217/fon.09.120. Future Oncol. 2009. PMID: 20001802 Review.
-
Critical role of lysophospholipids in the pathophysiology, diagnosis, and management of ovarian cancer.Cancer Treat Res. 2002;107:259-83. doi: 10.1007/978-1-4757-3587-1_12. Cancer Treat Res. 2002. PMID: 11775454 Review.
Cited by
-
Sp-1 and c-Myc mediate lysophosphatidic acid-induced expression of vascular endothelial growth factor in ovarian cancer cells via a hypoxia-inducible factor-1-independent mechanism.Clin Cancer Res. 2009 Jan 15;15(2):492-501. doi: 10.1158/1078-0432.CCR-08-1945. Clin Cancer Res. 2009. PMID: 19147754 Free PMC article.
-
Lysophosphatidic Acid Up-Regulates Hexokinase II and Glycolysis to Promote Proliferation of Ovarian Cancer Cells.Neoplasia. 2015 Sep;17(9):723-734. doi: 10.1016/j.neo.2015.09.003. Neoplasia. 2015. PMID: 26476080 Free PMC article.
-
Ovarian epithelial cancer: a role for PGE2-synthesis and signalling in malignant transformation and progression.Mol Cancer. 2006 Nov 16;5:62. doi: 10.1186/1476-4598-5-62. Mol Cancer. 2006. PMID: 17107625 Free PMC article.
-
Association of lipid metabolism with ovarian cancer.Curr Oncol. 2010 Oct;17(5):6-11. doi: 10.3747/co.v17i5.668. Curr Oncol. 2010. PMID: 20975872 Free PMC article.
-
Regulators of G-Protein signaling RGS10 and RGS17 regulate chemoresistance in ovarian cancer cells.Mol Cancer. 2010 Nov 2;9:289. doi: 10.1186/1476-4598-9-289. Mol Cancer. 2010. PMID: 21044322 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous